In the BioHarmony Drug Report Database

"Preview" Icon

Ambenonium

Mytelase (ambenonium) is a small molecule pharmaceutical. Ambenonium was first approved as Mytelase on 1982-01-01. It is used to treat myasthenia gravis in the USA.

 

Trade Name

 

Mytelase
 

Common Name

 

ambenonium
 

ChEMBL ID

 

CHEMBL1652
 

Indication

 

myasthenia gravis
 

Drug Class

 

Quaternary ammonium derivatives

Image (chem structure or protein)

Ambenonium structure rendering